Spectral Medical Inc.
EDT.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.57% | 7.63% | -0.41% | -7.75% | 6.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.57% | 7.63% | -0.41% | -7.75% | 6.61% |
| Cost of Revenue | 34.30% | 50.71% | 54.59% | 30.87% | 0.08% |
| Gross Profit | -11.13% | -26.95% | -37.20% | -35.01% | 14.02% |
| SG&A Expenses | 15.76% | 19.06% | 40.22% | 25.55% | 57.98% |
| Depreciation & Amortization | 180.84% | 179.10% | 42.87% | 11.42% | 35.26% |
| Other Operating Expenses | -67.20% | 454.07% | 857.59% | 4,387.10% | 1,233.92% |
| Total Operating Expenses | 19.12% | 28.19% | 43.82% | 27.46% | 56.72% |
| Operating Income | -20.45% | -32.05% | -53.92% | -34.89% | -70.78% |
| Income Before Tax | -141.85% | -107.31% | -171.24% | -95.88% | -36.36% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -141.85% | -107.31% | -171.24% | -95.88% | -36.36% |
| Earnings from Discontinued Operations | 97.71% | 92.28% | 96.33% | 95.90% | 41.90% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -112.60% | -69.31% | -87.73% | -34.22% | 2.05% |
| EBIT | -20.45% | -32.05% | -53.92% | -34.89% | -70.78% |
| EBITDA | -21.03% | -32.83% | -55.70% | -36.39% | -73.97% |
| EPS Basic | -110.90% | -66.67% | -82.42% | -29.81% | 5.74% |
| Normalized Basic EPS | -139.29% | -101.34% | -160.87% | -84.44% | -46.09% |
| EPS Diluted | -110.90% | -66.67% | -82.42% | -29.81% | 5.74% |
| Normalized Diluted EPS | -139.29% | -101.34% | -160.87% | -84.44% | -46.09% |
| Average Basic Shares Outstanding | 0.82% | 1.48% | 2.32% | 3.23% | 5.09% |
| Average Diluted Shares Outstanding | 0.82% | 1.48% | 2.32% | 3.23% | 5.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
